tiprankstipranks
InnoCan Pharma (INNPF)
OTHER OTC:INNPF
Holding INNPF?
Track your performance easily

InnoCan Pharma (INNPF) Technical Analysis

13 Followers

Summary of all the Indicators

Overall Consensus
Buy
10Bullish
6Neutral
5Bearish
Technical Analysis Consensus
Buy
2Bullish
6Neutral
1Bearish
Moving Average Consensus
Buy
8Bullish
0Neutral
4Bearish
InnoCan Pharma’s (INNPF) Moving Averages Convergence Divergence (MACD) indicator is >-0.01, suggesting InnoCan Pharma is a Sell.
InnoCan Pharma’s (INNPF) 20-Day exponential moving average is 0.13, while InnoCan Pharma’s (INNPF) share price is $0.157, making it a Buy.
InnoCan Pharma’s (INNPF) 50-Day exponential moving average is 0.14, while InnoCan Pharma’s (INNPF) share price is $0.157, making it a Buy.

InnoCan Pharma (INNPF) Pivot Points

Jan 10, 2025, 10:18 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.08
0.10
0.11
0.13
0.14
0.16
0.17
Fibonacci
0.10
0.11
0.12
0.13
0.14
0.15
0.16
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

InnoCan Pharma (INNPF) Moving Averages

Jan 10, 2025, 10:18 PM
Period
Simple
Exponential
MA5
0.13Buy
0.13Buy
MA10
0.13Buy
0.13Buy
MA20
0.14Buy
0.13Buy
MA50
0.13Buy
0.14Buy
MA100
0.14Sell
0.15Sell
MA200
0.17Sell
0.17Sell
InnoCan Pharma’s (INNPF) 10-Day exponential moving average is 0.13, while InnoCan Pharma’s (INNPF) share price is $0.157, making it a Buy.
InnoCan Pharma’s (INNPF) 100-Day exponential moving average is 0.15, while InnoCan Pharma’s (INNPF) share price is $0.157, making it a Sell.
InnoCan Pharma’s (INNPF) stock price is $0.157 and InnoCan Pharma’s (INNPF) 50-day simple moving average is 0.13, creating a Buy signal.
InnoCan Pharma’s (INNPF) stock price is $0.157 and InnoCan Pharma’s (INNPF) 100-day simple moving average is 0.14, creating a Sell signal.
InnoCan Pharma’s (INNPF) stock price is $0.157 and InnoCan Pharma’s (INNPF) 200-day simple moving average is 0.17, creating a Sell signal.

InnoCan Pharma (INNPF) Technical Indicators

Jan 10, 2025, 10:18 PM
Name
Value
Implied Action
RSI (14)
52.51
Neutral
STOCH (9,6)
43.68
Neutral
STOCHRSI (14)
43.68
Neutral
MACD (12,26)
>-0.01
Sell
ADX (14)
28.02
Neutral
Williams %R
-44.83
Buy
CCI (14)
29.62
Neutral
ATR (14)
0.03
-
Ultimate Oscillator
54.28
Neutral
ROC
0.00
-
InnoCan Pharma’s (INNPF) Relative Strength Index (RSI) is 52.51, creating a Neutral signal.
InnoCan Pharma’s (INNPF) Trend Strength Indicator (ADX) is 28.02, creating a Neutral signal.
InnoCan Pharma’s (INNPF) Commodity Channel Index (CCI) is 29.62, creating a Neutral signal.

FAQ

Is INNPF a Buy, Hold, or Sell?
Based on INNPF’s technical indicators, INNPF is a Buy.
    What is INNPF’s RSI (14)?
    INNPF’s RSI (14) is 52.51, which suggests INNPF is a Neutral.
      What is INNPF’s MACD?
      INNPF’s MACD is >-0.01, which suggests INNPF is a Sell.
        What is INNPF’s 5-day moving average?
        INNPF’s 5-day moving average is 0.13, which suggests INNPF is a Buy.
          What is INNPF’s 20-day moving average?
          INNPF 20-day moving average is 0.14, which suggests INNPF is a Buy.
            What is INNPF’s 50-day moving average?
            INNPF’s 50-day moving average is 0.13, which suggests INNPF is a Buy.
              What is INNPF’s 200-day moving average?
              INNPF’s 200-day moving average is 0.17, which suggests INNPF is a Sell.
                What is INNPF’s Williams % R (14)?
                INNPF’s Williams % R (14) is -44.83, which suggests INNPF is a Buy.
                  What is INNPF’s CCI (14)?
                  INNPF’s CCI (14) is 29.62, which suggests INNPF is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis